What are the steps of a safety fast for an infant on a stable intravenous dextrose infusion (>60 mg/dL) who is tolerating full enteral feeds?

Safety Fast Protocol for Infants on IV Dextrose Tolerating Full Enteral Feeds

For an infant on stable IV dextrose (maintaining glucose >60 mg/dL) who is tolerating full enteral feeds, perform a safety fast for 15-18 hours to confirm resolution of hyperinsulinism before discontinuing dextrose. 1

Step-by-Step Safety Fast Protocol

1. Timing and Prerequisites

• Ensure glucose levels have been stable >70 mg/dL for at least 2-4 weeks on current therapy 1
• Confirm infant is tolerating full enteral feeds without issues
• Complete the fast only when ready to prove resolution of hyperinsulinism

2. Duration of Fast

• 15-18 hours is the standard duration 1
• This extended period is necessary because infants have immature gluconeogenesis, limited glycogen stores, and large glucose demands 2

3. Monitoring During the Fast

• Check blood glucose frequently (specific intervals not defined in guidelines, but clinical practice suggests every 1-2 hours initially, then every 3-4 hours if stable)
• Monitor for symptoms of hypoglycemia: jitteriness, lethargy, poor feeding, seizures
• Glucose should remain >60-70 mg/dL throughout the fast

4. Managing IV Dextrose During the Fast

Critical consideration: Young infants (<2 years) are at risk for hypoglycemia with abrupt discontinuation of IV dextrose 2

• Taper the infusion gradually over 1-2 hours at the end rather than stopping abruptly 2
• Use an infusion pump that allows gradual rate reduction during the final 1-2 hours 2
• This prevents rebound hypoglycemia from sudden cessation of glucose delivery

5. Post-Fast Monitoring

• After successfully completing the 15-18 hour fast with glucose >60-70 mg/dL, monitor closely for at least 5 days 1
• Continue checking glucose levels during this observation period
• Watch for any recurrence of hypoglycemia

Important Caveats

Enteral feeding status: The evidence actually supports continuing enteral feeds during IV dextrose therapy rather than keeping infants NPO. Research shows fed infants have shorter duration of IV dextrose therapy and shorter hospital stays 3. However, for the actual safety fast to prove resolution, feeds must be withheld for the 15-18 hour test period.

Age considerations: The risk of hypoglycemia with fasting is much higher in young children (<2 years) compared to older children 2. Infants require more careful monitoring and gradual weaning.

Transient vs. persistent hyperinsulinism: If transient hyperinsulinism (e.g., perinatal stress-induced) is suspected, diazoxide doses may be reduced every 2-4 weeks if glucose remains stable >70 mg/dL, with the safety fast performed once off all medications 1.

What This Protocol Proves

A successful 15-18 hour safety fast with maintained euglycemia (>60-70 mg/dL) confirms:

• Resolution of hyperinsulinism
• Adequate counter-regulatory hormone function
• Sufficient glycogen stores and gluconeogenesis capacity
• Safety to discontinue IV dextrose support

Failure of the safety fast (glucose dropping <60 mg/dL) indicates persistent hyperinsulinism requiring continued treatment and endocrinology consultation 1.